Gsk (GSK) Gross Margin (2009 - 2026)
Gsk's Gross Margin was 73.11% in the quarter ended Sep 30, 2026, down 0.47 percentage points from 73.58% a year earlier but up 0.05 percentage points from the prior quarter.
Powered by 
Analysis
Gsk (GSK) Gross Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gsk's Gross Margin was 73.01% through Sep 30, 2026, up 0.72 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 72.40%, up 1.23 percentage points from the prior year.
- Gross Margin shows a five-year change of +4.95 percentage points (years ended Dec 2020 to Dec 2025).
- In earlier years, Gross Margin was 71.16% in the year ended Dec 31, 2024 (-0.60 pp), 71.76% in the year ended Dec 31, 2023 (+4.34 pp), 67.42% in the year ended Dec 31, 2022 (+0.47 pp) and 66.95% in the year ended Dec 31, 2021 (-0.50 pp).
- Quarterly Gross Margin has moved between 60.64% (the quarter ended Dec 31, 2021) and 75.42% (the quarter ended Mar 31, 2026) over five years.
- Compared with a year earlier, Gross Margin was higher in five of the last eight quarters, with an average year-over-year change of +0.95 percentage points.
- The best year-over-year quarter for Gross Margin over five years was the quarter ended Mar 31, 2023 (a gain of 9.84 percentage points); the worst was the quarter ended Mar 31, 2022 (a drop of 5.70 percentage points).
- Per Business Quant data, GSK's Gross Margin in the three quarters before the quarter ended Sep 30, 2026 was 73.05% (quarter ended Jun 30, 2026), 75.42% (quarter ended Mar 31, 2026) and 72.40% (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | - |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 72.78% |
| 10 | Gsk | 100.27 Bn | 83.11 Bn | 8.73 Bn | 73.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 73.11% |
| Jun 30, 2026 | 73.05% |
| Mar 31, 2026 | 75.42% |
| Dec 31, 2025 | 72.40% |
| Sep 30, 2025 | 73.58% |
| Jun 30, 2025 | 72.89% |
| Mar 31, 2025 | 74.23% |
| Dec 31, 2024 | 68.47% |
| Sep 30, 2024 | 70.08% |
| Jun 30, 2024 | 73.08% |
| Mar 31, 2024 | 73.24% |
| Dec 31, 2023 | 69.97% |
| Sep 30, 2023 | 72.11% |
| Jun 30, 2023 | 73.08% |
| Mar 31, 2023 | 72.05% |
| Dec 31, 2022 | 69.66% |
| Sep 30, 2022 | 69.05% |
| Jun 30, 2022 | 68.60% |
| Mar 31, 2022 | 62.21% |
| Dec 31, 2021 | 60.64% |
API Access
Gsk Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();